Last price paid | 2.60 | |
Change | +6.12% [ +0.15 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 11.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 20.07.2022 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +194.07% |
Year to date (YTD) | +142.99% |
1 month | +23.81% |
3 months | +36.84% |
1 year | +130.09% |
3 years | n.a. |
Issue price | 0.59 |
Underlying price on issue | 18.97 |
Premium | -0.09% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1164383858 |
Symbol | IXGANZ |
Security | 116438385 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Troy Ounce of Silver |
Underlying ISIN | XC0009653103 |
Funding level | 20.011900 |
Stop-loss level | 20.537300 |
Distance to stop-loss level | 32.86% |
Long/Short type | Long |
Subscription ratio | 4.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 13.07.2022 |
Premium | -9.20% |
Premium p.a. | n.a. |
Leverage | 3.94 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 10.575100 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
ABB Ltd | 51.48 |
NOVARTIS N | 100.50 |
ROCHE GS | 254.60 |
UBS | 28.01 |
Holcim | 83.02 |
Name | Price |
---|---|
KUEHNE & NAGEL | 256.80 |
Lonza Group | 516.80 |
SONOVA HLDG N | 275.50 |
Swiss Life Hldg | 675.80 |
Givaudan | 4'371.00 |